Literature DB >> 12626479

Invited review: Identifying new mouse models of cardiovascular disease: a review of high-throughput screens of mutagenized and inbred strains.

Karen L Svenson1, Molly A Bogue, Luanne L Peters.   

Abstract

The mouse is a proven model for studying human disease. Many strains exist that exhibit either natural or engineered genetic variation and thereby enable the elucidation of pathways involved in the development of cardiovascular disease. Although those mouse models have been fundamental to advancing our knowledge base, we are still at an early stage in understanding how genes contribute to complex disorders. There remains a need for new animal models that closely represent human disease. To expedite their development, we have established the Center for New Mouse Models of Heart, Lung, Blood, and Sleep Disorders at The Jackson Laboratory. We are using a phenotype-driven approach to identify mutations leading to atherosclerosis, hypertension, obesity, blood disorders, lung dysfunction, thrombosis, and disordered sleep. Our high-throughput, comprehensive phenotyping draws from two sources for new models: 1) the natural variation among over 40 inbred mouse strains and 2) chemically induced, whole-genome mutagenized mice. Here, we review our cardiovascular screens and present some hypertensive, obese, and cardiovascular models identified with this approach.

Entities:  

Mesh:

Year:  2003        PMID: 12626479     DOI: 10.1152/japplphysiol.01029.2003

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  29 in total

Review 1.  Functional genomics in rodent models of hypertension.

Authors:  Martin W McBride; Fadi J Charchar; Delyth Graham; William H Miller; Pamela Strahorn; Fiona J Carr; Anna F Dominiczak
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

2.  NMR-based metabolomics of urine for the atherosclerotic mouse model using apolipoprotein-E deficient mice.

Authors:  Gregory C Leo; Andrew L Darrow
Journal:  Magn Reson Chem       Date:  2009-12       Impact factor: 2.447

3.  Renal and endocrine changes in rats with inherited stress-induced arterial hypertension (ISIAH).

Authors:  Sergej Amstislavsky; Pia Welker; Jan-Henning Frühauf; Larissa Maslova; Ludmila Ivanova; Boye Jensen; Arkady L Markel; Sebastian Bachmann
Journal:  Histochem Cell Biol       Date:  2005-12-08       Impact factor: 4.304

Review 4.  Identifying novel genes for atherosclerosis through mouse-human comparative genetics.

Authors:  Xiaosong Wang; Naoki Ishimori; Ron Korstanje; Jarod Rollins; Beverly Paigen
Journal:  Am J Hum Genet       Date:  2005-05-19       Impact factor: 11.025

5.  RASA3 is a critical inhibitor of RAP1-dependent platelet activation.

Authors:  Lucia Stefanini; David S Paul; Raymond F Robledo; E Ricky Chan; Todd M Getz; Robert A Campbell; Daniel O Kechele; Caterina Casari; Raymond Piatt; Kathleen M Caron; Nigel Mackman; Andrew S Weyrich; Matthew C Parrott; Yacine Boulaftali; Mark D Adams; Luanne L Peters; Wolfgang Bergmeier
Journal:  J Clin Invest       Date:  2015-02-23       Impact factor: 14.808

6.  An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15.

Authors:  Liliana Fernandez; Douglas A Marchuk; Jennifer L Moran; David R Beier; Howard A Rockman
Journal:  Mamm Genome       Date:  2009-04-23       Impact factor: 2.957

7.  PPARG by dietary fat interaction influences bone mass in mice and humans.

Authors:  Cheryl L Ackert-Bicknell; Serkalem Demissie; Caralina Marín de Evsikova; Yi-Hsiang Hsu; Victoria E DeMambro; David Karasik; L Adrienne Cupples; Jose M Ordovas; Katherine L Tucker; Kelly Cho; Ernesto Canalis; Beverly Paigen; Gary A Churchill; Jiri Forejt; Wesley G Beamer; Serge Ferrari; Mary L Bouxsein; Douglas P Kiel; Clifford J Rosen
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

8.  Targeted deletion of the gamma-adducin gene (Add3) in mice reveals differences in alpha-adducin interactions in erythroid and nonerythroid cells.

Authors:  Kenneth E Sahr; Amy J Lambert; Steven L Ciciotte; Narla Mohandas; Luanne L Peters
Journal:  Am J Hematol       Date:  2009-06       Impact factor: 10.047

9.  Two pathways for cyclooxygenase-2 protein degradation in vivo.

Authors:  Masayuki Wada; Thomas L Saunders; Jason Morrow; Ginger L Milne; Kimberly P Walker; Sudhansu K Dey; Thomas G Brock; Mark R Opp; David M Aronoff; William L Smith
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

10.  Novel ENU-induced point mutation in scavenger receptor class B, member 1, results in liver specific loss of SCARB1 protein.

Authors:  Ioannis M Stylianou; Karen L Svenson; Sara K VanOrman; Yanina Langle; John S Millar; Beverly Paigen; Daniel J Rader
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.